The Future of Gene Patents and the Implications for Medicine
Jacob S. Sherkow
New York Law School
Henry T. Greely
Stanford Law School
September 23, 2013
173 JAMA Internal Medicine 1569, Sept. 2013
The Supreme Court decision in Myriad Genetics struck down the patenting of human genomic DNA. What will this mean for genetic testing and medicine, more broadly?
Number of Pages in PDF File: 2
Keywords: gene, genetic, patent, intellectual property, myriad, amp, medicine, BRCA, cancer
JEL Classification: K00, K11, O3, O34Accepted Paper Series
Date posted: September 15, 2013 ; Last revised: September 25, 2013
© 2015 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo3 in 1.516 seconds